Intraabdominal Infections: Clinical Trials

35 trials for Intraabdominal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 4 unknown, 3 terminated, 2 not yet recruiting. 35 Phase 2, 5 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 235Completed 23, Unknown 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 15Completed 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 35Completed 4, Unknown 1

Follow Intraabdominal Infections: new trials by email Literature Review of Intraabdominal Infections trials Research Report on Intraabdominal Infections

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH 47 - ALACARTE)
Shared decision-making, amoxicillin-clavulanate, Appendectomy - Acute Appendicitis
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris5602026-10-012026-10-05
Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis
Fuzheng Tongfu Jiedu prescription (FZTFJD), Placebo - Sepsis Abdominal, Gastrointestinal Dysfunction
Phase 1 / Phase 2Not yet recruitingDongzhimen Hospital, Beijing702025-04-252025-04-18
Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)
Piperacillin/tazobactam, Normal saline, CefTRIAXone Injection - Appendicitis Perforated
Phase 2CompletedMcMaster Children's Hospital162024-09-092026-07-07
Antibiotic Instillation in Appendicitis
Ceftriaxone, Intra-peritoneal Fluid Aspiration - Complicated Appendicitis, Acute Appendicitis
Phase 2CompletedJohns Hopkins All Children's Hospital1902023-01-052025-03-13
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD)
Phase 2 / Phase 3CompletedKarl Landsteiner Insitute for Nephrology and Haemato-Oncology122021-08-312025-08-11
Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis
Rectus Sheath Block with 0.25% bupivicaine with 1:200 000 epinephrine, Local Anesthetic Infiltration with 0.25% bupivicaine with 1:200 000 epinephrine - Appendicitis Acute
Phase 2CompletedUniversity of Alberta422021-05-282024-03-12
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
Allocetra-OTS, Placebo - Sepsis, Community-acquired Pneumonia
Phase 2CompletedEnlivex Therapeutics Ltd.1482020-11-302025-08-19
Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis
antibiotic rinse with suction, suction only - Perforated Appendicitis
Phase 2Active not recruitingPrisma Health-Upstate2002019-07-252026-01-27
The Role of Contrast Enhanced Ultrasound in Appendicitis
Sulfur hexafluoride lipid-type A microspheres - Acute Appendicitis
Phase 2CompletedChildren's Mercy Hospital Kansas City372019-01-042023-09-08
Non-operative Treatment of Acute Non-perforated Appendicitis
Meronem and flagyl, Appendectomy - Acute Appendicitis
Phase 2 / Phase 3CompletedKing Edward Medical University1802018-09-012021-02-18
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
LYS228, Standard of care therapy - Intra-abdominal Infections
Phase 2TerminatedNovartis Pharmaceuticals32018-05-152021-10-11
Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis
Combination of fosfomycin, metronidazole and rhGM-CSF (administered together intraperitoneally) and three days of antibiotics p.o., Standard antibiotics intravenously - Appendicitis Perforated
Phase 2CompletedHerlev Hospital132018-02-142018-10-16
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis
Pentaglobin®/Standard of Care - Peritonitis, Sepsis
Phase 2RecruitingRWTH Aachen University2002017-11-202026-06-11
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
Cholecalciferol (2000iu qd), Routine therapy for PD - Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency
Phase 2CompletedPeking University First Hospital602017-09-302021-08-18
Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy
Non-narcotic pain control - Appendicitis, Pain, Postoperative
Phase 1 / Phase 2WithdrawnUniversity of Utah2017-09-052020-02-07
The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis
A combination of fosfomycin, metronidazole and GM-CSF i.p. - Appendicitis
Phase 2CompletedHerlev Hospital142017-02-242019-05-29
Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
Ertapenem, Levofloxacin and Metronidazole, Endoscopic retrograde appendicitis therapy (ERAT), Appendectomy - Acute Appendicitis
Phase 2UnknownFirst Affiliated Hospital Xi'an Jiaotong University2402016-05-012016-06-03
Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Povidone-iodine irrigation, No irrigation - Acute, Perforated Appendicitis
Phase 2CompletedThe University of Texas Health Science Center, Houston1002016-04-012019-04-17
Nebulized Analgesia for Laparoscopic Appendectomy Trial
Ropivacaine, Normal saline - Appendicitis
Phase 1 / Phase 2UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre2002016-01-012016-03-22
Comparative Evaluation of Intra-operative Peritoneal Lavage With Super Oxidized Solution and Normal Saline in Peritonitis Cases
Super Oxidized Solution in group I - Peritonitis
Phase 2CompletedMaharishi Markendeswar University (Deemed to be University)2902014-12-012016-08-30

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Appendicitis (16)  ·  Peritonitis (8)  ·  Sepsis (5)  ·  Infections (4)  ·  Ototoxicity (2)  ·  Abdominal Abscess (1)  ·  Abscess (1)  ·  Agnosia (1)  ·  Bacterial Infections (1)  ·  Burns (1)  ·  Cholecystitis, Acute (1)  ·  Community-Acquired Pneumonia (1)  ·  Deafness (1)  ·  Enterocolitis, Necrotizing (1)

Broader conditions

Infections (31)  ·  Digestive System Diseases (26)  ·  Gastroenteritis (17)  ·  Gastrointestinal Diseases (17)  ·  Intestinal Diseases (17)  ·  Cecal Diseases (16)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Peritoneal Diseases (8)  ·  Inflammation (6)  ·  Systemic Inflammatory Response Syndrome (4)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Bacterial Infections and Mycoses (2)

Interventions

Metronidazole (6)  ·  Meropenem (4)  ·  Appendectomy (3)  ·  Piperacillin, Tazobactam Drug Combination (3)  ·  Saline Solution (3)  ·  Acetylcysteine (2)  ·  Ceftriaxone (2)  ·  Clindamycin (2)  ·  Ertapenem (2)  ·  Gentamicins (2)  ·  Ropivacaine (2)  ·  3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Ampicillin (1)  ·  Aztreonam (1)

Sponsors

Herlev Hospital (2)  ·  Merck Sharp & Dohme LLC (2)  ·  TC Erciyes University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Astellas Pharma Inc (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Critical Biologics Corporation (1)  ·  Dongzhimen Hospital, Beijing (1)  ·  Enlivex Therapeutics Ltd. (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  GlaxoSmithKline (1)  ·  Göteborg University (1)  ·  Helsinki University Central Hospital (1)  ·  Johns Hopkins All Children's Hospital (1)  ·  Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1)

Countries

United States (11)  ·  Canada (5)  ·  China (4)  ·  France (4)  ·  Austria (3)  ·  Belgium (3)  ·  Denmark (3)  ·  Spain (3)  ·  Turkey (Türkiye) (3)  ·  Finland (2)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Mexico (2)  ·  Czechia (1)

Top investigators

Bulent Tokgoz, MD (1)  ·  Danny Benjamin, MD, PhD, MPH (1)  ·  Gernot Marx, Univ.-Prof. (1)  ·  Ismail Kocyigit, MD (1)  ·  Jie Dong (1)  ·  Jin Liu, Dr (1)  ·  Kent Lundholm (1)  ·  KuoJen Tsao, MD (1)  ·  Martin F Wiesholzer, MD (1)  ·  Martin Sanchez-Aguilar, MSc (1)  ·  Michael H Livingston, MD, MSc (1)

Results publications

PMID 11427329, PMID 17359318, PMID 19358184, PMID 21551083, PMID 21958060, PMID 22249106, PMID 22955430, PMID 23772043, PMID 25073872, PMID 25581711, PMID 26270686, PMID 27437029, PMID 27503659, PMID 30061293, PMID 30366723, PMID 30832742, PMID 31040341, PMID 31567357, PMID 31779675, PMID 32432123, PMID 32914187, PMID 33902072, PMID 41202087

NIH funding

2008 (1), 2016 (1), 2025 (1)